Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for InMed Pharmaceuticals Inc. (INM : NSDQ)

• Company Description    InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. It engages in developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol in diseases with unmet medical need. InMed Pharmaceuticals Inc. is based in VANCOUVER, BC. Number of Employees: 6

• Price / Volume Information    Yesterday's Closing Price: $1.44 Daily Weekly Monthly 20 Day Moving Average: 37,138 shares Shares Outstanding: 3.31 (millions) Market Capitalization: $4.77 (millions) Beta: 0.93 52 Week High: $2.33 52 Week Low: $0.58 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 2.86% 3.94% 12 Week -4.00% -6.34% Year To Date 35.85% 12.08%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL Suite 1800 - 500 West Georgia St. - VANCOUVER,A1 V6B 0M3 CAN ph: 604-669-7207 fax: - ir@inmedpharma.com http://www.inmedpharma.com

• General Corporate Information    Officers Eric A. Adams - Chief Executive Officer; President and Director Andrew Hull - Chairman and Director Netta Jagpal - Chief Financial Officer Neil Klompas - Director Nicole Lemerond - Director Peer Information InMed Pharmaceuticals Inc. (GSAC) InMed Pharmaceuticals Inc. (CASIF) InMed Pharmaceuticals Inc. (ALCD.) InMed Pharmaceuticals Inc. (OMNN) InMed Pharmaceuticals Inc. (CGPI.) InMed Pharmaceuticals Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 457637700 SIC: 2834 Fiscal Year Fiscal Year End: June Last Reported Quarter: 03/01/26 Next Expected EPS Date: 11/05/26 Share - Related Items Shares Outstanding: 3.31 Most Recent Split Date: 11.00 (0.05:1) Beta: 0.93 Market Capitalization: $4.77 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/05/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 4.44 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 64.43% vs. Previous Quarter: -35.29% Sales Growth vs. Year Ago Period: -26.26% vs. Previous Quarter: -26.79% ROE 09/30/26 - - 06/30/26 - -156.08 03/31/26 - -85.94 ROA 09/30/26 - - 06/30/26 - -123.90 03/31/26 - -72.40 Current Ratio 09/30/26 - - 06/30/26 - 1.37 03/31/26 - 3.12 Quick Ratio 09/30/26 - - 06/30/26 - 1.37 03/31/26 - 3.12 Operating Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Net Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Pre-Tax Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Book Value 09/30/26 - - 06/30/26 - 0.32 03/31/26 - 2.08 Inventory Turnover 09/30/26 - - 06/30/26 - 0.00 03/31/26 - -0.15 Debt-to-Equity 09/30/26 - - 06/30/26 - 0.00 03/31/26 - 0.00 Debt-to-Capital 09/30/26 - - 06/30/26 - 0.00 03/31/26 - 0.44

Powered by Zacks Investment Research ©